Envelope-to: renata@bewonderful.com.br
Delivery-date: Wed, 31 Jul 2024 16:04:38 -0300
From: Gabriel Rocha Hora <gabriel.hora@hypera.com.br>
To: Renata de Cristofaro <renata@bewonderful.com.br>
CC: Aline De Oliveira Inacio <aline.inacio@hypera.com.br>, Maria Eduarda Silva
 Camargo <maria.e.camargo@hypera.com.br>, Thais De Almeida Batista
	<thais.d.batista@hypera.com.br>
Subject:
 =?iso-8859-1?Q?RES:_Re:_RES:_RES:_RES:_RES:_RES:_Neo_Qu=EDmica_|_Ativa=E7?=
 =?iso-8859-1?Q?=E3o_Trade:_AGOSTO_2024_(layout_Neo_Pharma_Excel=EAncia_-_?=
 =?iso-8859-1?Q?V04_COM_VARIANTES-_para_valida=E7=E3o)?=
Thread-Topic:
 =?iso-8859-1?Q?Re:_RES:_RES:_RES:_RES:_RES:_Neo_Qu=EDmica_|_Ativa=E7=E3o_?=
 =?iso-8859-1?Q?Trade:_AGOSTO_2024_(layout_Neo_Pharma_Excel=EAncia_-_V04_C?=
 =?iso-8859-1?Q?OM_VARIANTES-_para_valida=E7=E3o)?=
Thread-Index: AQHa42QhNETFrneRMEO6p60FqDIbIrIRHISwgAAT+MA=
Date: Wed, 31 Jul 2024 19:03:39 +0000
Message-ID:
 <CPUP152MB44508AF5CC424214E6D5E5B2D0B12@CPUP152MB4450.LAMP152.PROD.OUTLOOK.COM>
References: <br9K1rWGYoJE3UHWQSjLeMgP2bV1BlwlSthMPqCU@www.mkt.tools>
 <CPUP152MB44500B446FBEC082CB0D16BDD0B12@CPUP152MB4450.LAMP152.PROD.OUTLOOK.COM>
In-Reply-To:
 <CPUP152MB44500B446FBEC082CB0D16BDD0B12@CPUP152MB4450.LAMP152.PROD.OUTLOOK.COM>
Accept-Language: pt-BR, en-US
Content-Language: pt-BR
x-ms-exchange-antispam-messagedata-chunkcount: 1
x-ms-exchange-antispam-messagedata-0:
 =?iso-8859-1?Q?QYwIIyGY6fNQUh4nCNwBKQDs4POydq2ICa7soqre9xmxtR7A3/Uzy6SIB+?=
 =?iso-8859-1?Q?LIdCHxq2YgL94rC9awXkeffdyXULWp+O5i5zolUXEFoCS1wk4HkWji0uK3?=
 =?iso-8859-1?Q?Ovethx/YWb7ZoJICD2ray5m4n2IXQp6CK/U6fTjjkUzwg9HcvaEqr8ra6T?=
 =?iso-8859-1?Q?IkVULntc6jKylNgNgav1XO6pCIZI3KCMMZuDShRM4w5whEfX6NsDhjXqsQ?=
 =?iso-8859-1?Q?NaAUjR/f6kXvieQL9i9M6PALhSVTzlVr730vb9Q8PtY2nOypqJq1AAsgw9?=
 =?iso-8859-1?Q?da+LqUzaa5QxZzBIJdH/84qnsu4JlJWjEvy6shD6r42dJt7fVkzR1ztjaM?=
 =?iso-8859-1?Q?2ys/07G1pFty0QVDhSYejWn8TvISqxaMh/pCs3frb8sfDALskn41tXEIFz?=
 =?iso-8859-1?Q?qet9G1GrbPX/ZDPHWOwxzqedHRGMKMQS95DR4ipdAK41Bzde/QrBrNEyMt?=
 =?iso-8859-1?Q?SWBSGvxH8oJ3sjSJJQNXfwZENfYxiRFjf3hLWFphmCUdR5CSW+ZtS9AQIY?=
 =?iso-8859-1?Q?rBwQF99bSt18MaiiM9DaziIwbdpPPbgXfkxW+ZFN5G/KF9IimVWuc3abwo?=
 =?iso-8859-1?Q?iRJ/ivq/rAvI7Cy5d/QrcVZGSCE7TXSy1GT8n3by63bSLMXzJtl+3TWFGz?=
 =?iso-8859-1?Q?X6bhXW312QKi/rj1/7593zxiLy5S8Z9G3xgIiTHJCmb2pqXASrBITtg3C8?=
 =?iso-8859-1?Q?YrwXbXnODpN0wUCo5JbvF1W78ADU2KK9I6OlW3PCdfykMK3BkfF4gZhoxJ?=
 =?iso-8859-1?Q?Di2G2Aj7RLCglx00X0rTNLcRF9N9fWNRosdBhoeNA+1EqpoZschpjUMFJk?=
 =?iso-8859-1?Q?q/32SAjpKjbppqrWeRmPO+MSLNwTBKqQFHs51sVmPczzB5i1Q+OlphY2Cl?=
 =?iso-8859-1?Q?KBn2giEQqoL2fGA/sfgjhip0cDJZsFtLBi5wbtWKF+95bTe4e8K1q+qoz/?=
 =?iso-8859-1?Q?ecxE+LbruwR3S42Txx4kbnhobTT1GLNgoXluyKceJ/7rIeXnRUG+9CZcrf?=
 =?iso-8859-1?Q?1dX9jN7exbca+McW+hvOtKTO5wLtI9/hBSxUyiFXwlzymHjS1Rn+mUJa/T?=
 =?iso-8859-1?Q?KUTplwj54eQbGxPdSRVFK+ZvlYuU6fnbIyG90V6PEei6/ehcvjOU8Sxf1J?=
 =?iso-8859-1?Q?M5JJOsQqsmHInUzp6Rilk2jvjzfP3J2wehq8xsPqK8tWaqGUDWuieYNWhe?=
 =?iso-8859-1?Q?iMWQ7m47YbeJrby/sfVvX15zSEJmyzkaq4R8HZw1h1p7vaabxagIvKIruB?=
 =?iso-8859-1?Q?e+NoOxHNlG74Hm8V24uMtRT+M4fSwkR/GL1ckCfmO4gKAGlacjjaiPyAWe?=
 =?iso-8859-1?Q?wvJv/+04szJn5P82IirkX/J2NnXL6XwsPoI7uZ/E1UNGSIXFh1FVygtW2S?=
 =?iso-8859-1?Q?hz21xHSn48Ob5sLnTypFM3dOS7FkpuZCtD6EsZEjIADxZHEAtUr47UdxVo?=
 =?iso-8859-1?Q?Ucxg9wRtIPCe8p6Yvd7MgaPF8RQ3H3WKJFFb0IOjBHbI4nje0wsqlq6ZtM?=
 =?iso-8859-1?Q?rgA3QQkJugk5ByJXiBo/klb6lqgnuN9KLiN8YUn3ca2HJ4SZo7fbE0TTz1?=
 =?iso-8859-1?Q?4jkwcQZsl0qBKqjhGTVtZK2mqS5y7E5/0HrdKsBZduKVwxybQ5EoHNp8Uh?=
 =?iso-8859-1?Q?4dGO9n+7EotA00X4zaHQ9IAzUXmN0JLSJlSfwVITUSQ7rMPgm5TrsAHg?=
 =?iso-8859-1?Q?=3D=3D?=
Content-Type: multipart/mixed;
	boundary=\"_004_CPUP152MB44508AF5CC424214E6D5E5B2D0B12CPUP152MB4450LAMP_\"
MIME-Version: 1.0
X-OriginatorOrg: hypera.com.br
X-MS-Exchange-CrossTenant-AuthAs: Internal
X-MS-Exchange-CrossTenant-AuthSource: CPUP152MB4450.LAMP152.PROD.OUTLOOK.COM
X-MS-Exchange-CrossTenant-Network-Message-Id: cd1048a3-82bf-443b-8e5b-08dcb1937d38
X-MS-Exchange-CrossTenant-originalarrivaltime: 31 Jul 2024 19:03:39.8888
 (UTC)
X-MS-Exchange-CrossTenant-fromentityheader: Hosted
X-MS-Exchange-CrossTenant-id: 3f7a3df4-f85b-4ca8-98d0-08b1034e6567
X-MS-Exchange-CrossTenant-mailboxtype: HOSTED
X-MS-Exchange-CrossTenant-userprincipalname: g1gmQBeMn93TPaw0BnW8MDkei3dwSe9mm4iYyu+uJw0lBMV2Aby1dpC4+1dLStv1d1KdeRkKXaocFPQeXACnDfx3aJRGnAMjyvjxpEqJZGI=
X-MS-Exchange-Transport-CrossTenantHeadersStamped: RO2P152MB5473
X-Spam-Status: No, score=-0.2
X-Spam-Score: -1
X-Spam-Bar: /
X-Ham-Report: Spam detection software, running on the system \"cloud.mkt.tools\",
 has NOT identified this incoming email as spam.  The original
 message has been attached to this so you can view it or label
 similar future email.  If you have any questions, see
 root\\@localhost for details.
 Content preview:  Conforme solicitado via WhatsApp, segue os EAN\'s das mec?nicas
    de Neo Pharma Excel?ncia: Cesta de Similares: DS_MATERIAL_MD CD_EAN ALERGIDEX
    XPE CT FR PET 1X120ML 7896714225586 DESRINITE 120MG CT BL AL X 10 CPRV 7896714290591
    DESRINITE 180MG CT BL AL X 10 CPRV 7896714290584 HEMOVIRTUS PRO POMADA CT
    BG 1X30G [...] 
 Content analysis details:   (-0.2 points, 5.0 required)
  pts rule name              description
 ---- ---------------------- --------------------------------------------------
 -0.0 SPF_PASS               SPF: sender matches SPF record
 -0.0 SPF_HELO_PASS          SPF: HELO matches SPF record
  0.0 HTML_MESSAGE           BODY: HTML included in message
 -0.1 DKIM_VALID_EF          Message has a valid DKIM or DK signature from
                             envelope-from domain
 -0.1 DKIM_VALID             Message has at least one valid DKIM or DK signature
  0.1 DKIM_SIGNED            Message has a DKIM or DK signature, not necessarily
                             valid
 -0.1 DKIM_VALID_AU          Message has a valid DKIM or DK signature from
                             author\'s domain
  0.0 KAM_SHORT              Use of a URL Shortener for very short URL
X-Spam-Flag: NO